AHA Conference Repository

American Heart Association

Frederick Raal

Is this you? Login and claim your profile. Then, you can add your biography and additional Information.

Showing 1 Abstract.

Efficacy and Safety of Lerodalcibep, a Third Generation PCSK9 Inhibitor, in 703 Heterozygous Familial Hypercholesterolemia Subjects in the Open Label Extension Trial

Meeting name: Scientific Sessions 2024 , 2024 , Chicago, Illinois

Authors: Raal Frederick , Fourie Nyda , Scott Russell , Blom Dirk , Kayikcioglu Meral , Vest Jeff , Kallend David , Stein Evan

Keywords: LDL, Apolipoproteins, PCSK9, Hypercholesterolemia